Related Experiment Video
Updated: Aug 20, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells]
Yang Xu1, Yi-Hua Wang, Ji-Dong Gao
1Department of Molecular Immunology, Cancer Institute (Hospital), Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100021, China.
Objective:
To study the inhibitory effect of RNA interference (RNAi) on c-myc expression in hepatocellular carcinoma cell line, HepG2.
Methods:
Expression vector of c-myc gene-targeting small interference RNA (siRNA) was constructed (psilencer-c-myc) and transfected into HepG2 cells by lipofectamine, and the unloaded vector was used as control (mock). The expression of c-myc mRNA and protein was identified by quantitive PCR and Western blot. Apoptosis of the transfected cells was examined by flow cytometry and immunofluorescent microscopy.
Results:
After HepG2 cells were transfected with psilencer-c-myc, the expression of c-myc mRNA and protein was suppressed with an inhibition rate of 67% compared with the mock-transfected cells. Apoptosis was identified in the transfected HepG2 cells.
Conclusion:
The expression of c-myc at transcriptional and translational levels in HepG2 cells transfected with siRNA is markedly inhibited, which may be associated with the induction of apoptosis.
Insights
RNA interference targeting the c-myc gene significantly inhibited its expression in hepatocellular carcinoma cells (HepG2). This suppression of c-myc may induce cancer cell apoptosis.
Area of Science:
- Molecular biology
- Cancer research
- Gene silencing
Context:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- The c-myc oncogene plays a crucial role in HCC development and progression.
- Targeting oncogenic pathways is a key strategy in cancer therapy.
Purpose:
- To investigate the efficacy of RNA interference (RNAi) in suppressing c-myc expression in HepG2 cells.
- To evaluate the impact of c-myc inhibition on hepatocellular carcinoma cell apoptosis.
Summary:
- A c-myc gene-targeting small interfering RNA (siRNA) expression vector (psilencer-c-myc) was constructed and transfected into HepG2 cells.
- Quantitative PCR and Western blot confirmed significant suppression of c-myc mRNA and protein levels (67% inhibition).
- Flow cytometry and immunofluorescent microscopy demonstrated increased apoptosis in transfected cells.
Impact:
- Demonstrates successful inhibition of c-myc at both transcriptional and translational levels in HCC cells using siRNA.
- Suggests a potential therapeutic strategy for hepatocellular carcinoma by targeting c-myc and inducing apoptosis.
Related Concept Videos
Experimental RNAi
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
